Guardant Health Secures New Commercial Payor Coverage for Liquid Biopsy Cancer Profiling Test

Guardant Health said Wednesday that it has received new commercial health plan coverage for its Guardant360/Guardant 360 CDx liquid biopsy cancer profiling test from Anthem Blue Cross and Blue Shield, Aetna, and Humana.

Source: https://www.xifin.com/resources/industry-news/202306/guardant-health-secures-new-commercial-payor-coverage-liquid-biopsy